The 2 most recent market catalysts affecting $BOLT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 12, 2026
Corporate Catalyst
Bearish
Impact 75
Bolt Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
The headline indicates a significant negative corporate catalyst for Bolt Biotherapeutics. Worse-than-expected financial results often lead to immediate stock price declines as inv…
Aug 11, 2026
Corporate Catalyst
Bearish
Impact 95
Bolt Biotherapeutics Q2 EPS $(4.57) Misses $(2.88) Estimate, Sales $5.000K Miss $500.000K Estimate
Bolt Biotherapeutics' Q2 earnings report reveals a substantial underperformance, with both EPS and sales falling far short of analyst expectations. The 99.00% sales miss and 99.72%…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.